PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS

被引：0

作者：

Habib, Ali A. ^{[1
]}

Druzdz, Artur ^{[2
]}

Grosskreutz, Julian ^{[3
]}

Kaminski, Henry ^{[4
]}

Mantegazza, Renato ^{[5
]}

Sacconi, Sabrina ^{[6
]}

Utsugisawa, Kimiaki ^{[7
]}

Vissing, John ^{[8
]}

Vu, Tuan ^{[9
]}

Morel, Thomas ^{[10
]}

Boehnlein, Marion ^{[11
]}

Woltering, Franz ^{[11
]}

Bozorg, Ali ^{[12
]}

Gayfieva, Maryam ^{[13
]}

Bril, Vera ^{[14
]}

机构：

[1] Univ Calif Irvine, Orange, CA 92668 USA

[2] Municipal Hosp Poznan, Poznan, Poland

[3] Univ Lubeck, Lubeck, Germany

[4] George Washington Univ, Med Ctr, Washington, DC 20037 USA

[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy

[6] CHU Nice, Nice, France

[7] Hanamaki Gen Hosp, Hanamaki, Japan

[8] Univ Copenhagen, Rigshosp, Copenhagen, Denmark

[9] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA

[10] UCB Pharma, Brussels, Belgium

[11] UCB Pharma, Monheim, Germany

[12] UCB Pharma, Morrisville, NC USA

[13] UCB Pharma, Slough, Berks, England

[14] Univ Hlth Network, Toronto, ON, Canada

来源：

MUSCLE & NERVE | 2022年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S19 / S20

页数：2

共 50 条

[1] Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali A.
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Greve, Bernhard
Woltering, Franz
Kaminski, Henry J.
LANCET NEUROLOGY, 2023, 22 (05): : 383 - 394
[2] EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MYCARING)
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali A.
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Woltering, Franz
Bozorg, Ali
Gayfieva, Maryam
Kaminski, Henry
MUSCLE & NERVE, 2022, 65 : S35 - S35
[3] OUTCOMES FROM RAISE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ZILUCOPLAN IN GENERALIZED MYASTHENIA GRAVIS
Howard, James F., Jr.
Genge, Angela
Hussain, Yessar
Kaminski, Henry J.
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Brock, Melissa
Boroojerdi, Babak
Vanderkelen, Mark
de la Borderie, Guillemette
Duda, PetraW
Leite, M. Isabel
MUSCLE & NERVE, 2022, 65 : S34 - S35
[4] Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials
Dinan, Michaela A.
Compton, Kate L.
Dhillon, Jatinder K.
Hammill, Bradley G.
DeWitt, Esi Morgan
Weinfurt, Kevin P.
Schulman, Kevin A.
MEDICAL CARE, 2011, 49 (04) : 415 - 419
[5] Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised double-blind, multicentre, placebo-controlled phase 3 trial
Habib, Ali A.
Zhao, Chongbo
Aban, Inmaculada
Franca Jr, Marcondes Cavalcante
Jose, Jorge Gustavo
Hoerste, Gerd Meyer zu
Klimiec-Moskal, Elzbieta
Pulley, Michael T.
Tavolini, Dario
Krumova, Petranka
Lennon-Chrimes, Sian
Smith, Jillian
Thanei, Gian-Andrea
Blondeau, Kathleen
Vodopivec, Ivana
Wolfe, Gil, I
Murai, Hiroyuki
LANCET NEUROLOGY, 2025, 24 (02): : 117 - 127
[6] ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Woltering, Franz
Kaminski, Henry
MUSCLE & NERVE, 2022, 66 : S112 - S112
[7] Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study
Habib, Ali A.
Sacconi, Sabrina
Antonini, Giovanni
Cortes-Vicente, Elena
Grosskreutz, Julian
Mahuwala, Zabeen K.
Mantegazza, Renato
Pascuzzi, Robert M.
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Wiendl, Heinz
Boehnlein, Marion
Greve, Bernhard
Woltering, Franz
Bril, Vera
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
[8] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Bril, Vera
Szczudlik, Andrzej
Vaitkus, Antanas
Rozsa, Csilla
Kostera-Pruszczyk, Anna
Hon, Petr
Bednarik, Josef
Tyblova, Michaela
Koehler, Wolfgang
Toomsoo, Toomas
Nowak, Richard J.
Mozaffar, Tahseen
Freimer, Miriam L.
Nicolle, Michael W.
Magnus, Tim
Pulley, Michael T.
Rivner, Michael
Dimachkie, Mazen M.
Distad, B. Jane
Pascuzzi, Robert M.
Babiar, Donna
Lin, Jiang
Querolt Coll, Montse
Griffin, Rhonda
Mondou, Elsa
NEUROLOGY, 2023, 100 (07) : E671 - E682
[9] PRELIMINARY-RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS
TINDALL, RSA
ROLLINS, JA
PHILLIPS, JT
GREENLEE, RG
WELLS, L
BELENDIUK, G
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (12): : 719 - 724
[10] Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
Howard Jr, James F.
Bresch, Saskia
Genge, Angela
Hewamadduma, Channa
Hinton, John
Hussain, Yessar
Juntas-Morales, Raul
Kaminski, Henry J.
Maniaol, Angelina
Mantegazza, Renato
Masuda, Masayuki
Sivakumar, Kumaraswamy
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael
Zajda, Malgorzata
Boroojerdi, Babak
Brock, Melissa
de la Borderie, Guillemette
Duda, Petra W.
Lowcock, Romana
Vanderkelen, Mark
Leite, M. Isabel
LANCET NEUROLOGY, 2023, 22 (05): : 395 - 406

← 1 2 3 4 5 →